NeuroBo Pharmaceuticals News

Maxim Group Maintains NeuroBo Pharmaceuticals(NRBO.US) With Buy Rating, Maintains Target Price $10

Futu NewsAug 15 23:32

Buy Rating for NeuroBo Pharmaceuticals Based on Financial Stability and Promising Developmental Pipeline

TipRanksAug 15 23:07

Buy Rating on NeuroBo Pharmaceuticals: Strategic Alliances and Market Differentiation Potential

TipRanksAug 8 03:12

Maxim Group Maintains NeuroBo Pharmaceuticals(NRBO.US) With Buy Rating, Maintains Target Price $10

Futu NewsAug 1 01:31

Buy Rating Affirmed for NeuroBo Pharmaceuticals on Strategic Licensing and Promising Clinical Outcomes

TipRanksAug 1 01:19

Buy Rating Affirmed for NeuroBo Pharmaceuticals on Promising Obesity and MASH Drug Developments

TipRanksMay 17 22:51

Maxim Initiates NeuroBo Pharmaceuticals With Buy Rating, $10 Price Target

MT NewswiresMay 8 22:36

NeuroBo Pharmaceuticals Analyst Ratings

BenzingaMay 8 22:10

NeuroBO Pharmaceuticals (NRBO.US) was first covered by Maxim Group, giving it a buy rating, with a target price of $10.00.

Zhitong FinanceMay 8 22:10

Maxim Group Initiates Coverage On NeuroBo Pharmaceuticals With Buy Rating, Announces Price Target of $10

BenzingaMay 8 22:10

NeuroBo Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsDec 7, 2022 20:52